Navigation Links
Watson Completes Acquisition of Arrow Group
Date:12/2/2009

gnize the anticipated synergies and benefits of the Arrow acquisition; the impact of competitive products and pricing; the difficulty of predicting the timing or outcome of litigation; variability of revenue mix between the Company's Brand, Generic and Distribution business units; periodic dependence on a small number of products for a material source of net revenue or income; variability of trade buying patterns; changes in generally accepted accounting principles; risks that the carrying values of assets may be negatively impacted by future events and circumstances; timely and successful consummation and implementation of strategic initiatives; the timing and success of product launches; the difficulty of predicting the timing or outcome of product development efforts and FDA or other regulatory agency approvals or actions; the uncertainty associated with the identification and successful consummation of external business development transactions; market acceptance of and continued demand for Watson's products; costs and efforts to defend or enforce intellectual property rights; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to Watson's and its third party manufacturers' facilities, products and/or businesses; uncertainties related to the timing and outcome of litigation and other claims; changes in the laws and regulations, including Medicare and Medicaid, affecting among other things, pricing and reimbursement of pharmaceutical products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's quarterly report on Form 10-Q for the period ended September 30, 2009. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements.

(Logo: '/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds
2. Watson Names G. Frederick Wilkinson Executive Vice President, Global Brands
3. Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use
4. Watson Prices $850 Million of Senior Unsecured Notes
5. Watson Announces Limited Recall Of Fentanyl Transdermal System
6. Watson Pharmaceuticals and Arrow Group Receive FTC Second Request
7. Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG
8. Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
9. Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)
10. Watson CFO Mark W. Durand to Take Leave of Absence
11. Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... (PRWEB) August 01, 2014 ... Market Outlook to 2020", provides key market ... market. The report provides value, in millions ... average prices (in US dollars) within market ... Ultrasonic Generators and Argon Plasma Coagulation Generators. ...
(Date:8/1/2014)... 2014 Oxford Gene Technology (OGT) ... Its products include CytoSure heamatological cancer +SNP Array, ... ISCA UPD array, CytoSure ISCA sample tracking spike-ins ... services, such as targeted sequencing services, SureSeq Solid ... gene expression analysis, cytosure services and aCGH for ...
(Date:8/1/2014)... August 01, 2014 In today’s age, ... development of an individual. Hence, these methods need to ... employability skills can be inculcated. In this age of ... to these conventional methods. Thus, learning management systems help ... , As of now, these are proving to ...
(Date:8/1/2014)... HealthDay Reporter THURSDAY, July 31, ... doses of estrogen, along with some other formulations, may ... 50, new preliminary research suggests. "There are ... a staff scientist at the Fred Hutchinson Cancer Research ... cancer risk while other formulations do not raise risk." ...
(Date:8/1/2014)... Women who serve in the U.S. military are less ... new study suggests. Overall, members of the military ... found that women respond differently to their experience in ... concerns about sexual harassment or being treated unfairly, they ... assault, both within and outside the military, and women ...
Breaking Medicine News(10 mins):Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 2Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 3Health News:Oxford Gene Technology Market Size, Share, Analysis, Trends and Forecasts 2014 2Health News:Oxford Gene Technology Market Size, Share, Analysis, Trends and Forecasts 2014 3Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Some Birth Control Pills May Up Breast Cancer Risk 2Health News:Some Birth Control Pills May Up Breast Cancer Risk 3Health News:Women in Military Drink Less Than Civilians, Report Shows 2
... Ranbaxy Laboratories and Aurobinda Pharma were among some of ... UN Secretary General Kofi Annan // for their ... ,Annan complimented these companies for their efforts ... a meeting with their top executives at United Nations ...
... week of Asian countries, including China, on the global health ... substantial poultry losses and human deaths. ,"Health and ... to the meet here on July 27-28 to study how ... unprecedented in its geographical scope, spread and consequences," said a ...
... has claimed the lives of 271 people this year in ... ,Replying to the debate on cut motions in ... higher as information from interior areas had not reached the ... was "slow", he said this year 90 per cent of ...
... the ‘fat controller’ could offer new hope in treating ... of Dundee have claimed to uncover a link between ... the head of the international research team at Dundee ... of treatment for patients who suffer from these diseases. ...
... a complication, such as a hernia, within 6 months ... by HHS’ Agency// for Healthcare Research and Quality. The ... complications from obesity operations based on insurance claims data. ... among non-elderly obesity surgery patients with private insurance increased ...
... that recycling boxes are unreasonably heavy and could injure anyone ... said that any such injuries could trigger potential lawsuits. The ... could become too heavy when filled with a mixture of ... recommended weight limit. The report, which was compiled after a ...
Cached Medicine News:Health News:India to Host Asian Review Meet on Avian Flu 2Health News:Protein May Offer New Hope For Treatment Of Cystic Fibrosis 2Health News:Obesity Surgery Complication Rates Higher than Previously Thought 2
(Date:8/1/2014)... -- Aspire Technology Partners (Aspire) announced today that it has ... designation recognizes Aspire for delivering outstanding customer service to customers ... "Achieving exceptional results for our customers is core ... and CEO of Aspire. "We are pleased Cisco has recognized ... and are proud to be part of the Cisco channel." ...
(Date:8/1/2014)... , Aug. 1, 2014 ... of the "Global Medical Biosensors Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Medical biosensors ... help of physicochemical detectors. These biosensors monitor health ... invasive and non-invasive methods. They are cost-effective and ...
(Date:8/1/2014)... CHICAGO , Ill. and PALO ALTO, ... ABBV) and Cystic Fibrosis Research, Inc. (CFRI) today announced a ... the cystic fibrosis (CF) community through the CFChef Shares ... September 15, 2014, as part of AbbVie,s CFChef program ... – to encourage patients to maintain a healthy diet ...
Breaking Medicine Technology:Aspire Technology Partners Recognized By Cisco For Excellence In Customer Satisfaction 2Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3
... NEW YORK, June 13, 2011 Reportlinker.com ... is available in its catalogue: ... in Key SADC Countries ... aim of this research service is to ...
... 2011 Science, public health, and regulatory highlights from ... this document is designed for credentialed journalists. Release dates and ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... or enforcement actions due to legal limitations. ...
Cached Medicine Technology:Reportlinker Adds Distributor Analysis of the Pharmaceutical Industry in Key SADC Countries 2Reportlinker Adds Distributor Analysis of the Pharmaceutical Industry in Key SADC Countries 3
Designed to insert eye spheres using spring loaded plunger. Polished finish. Overall length: 125 mm, 4.9 inches....
Size: Medium. 22.50 mm by 24.00 mm. Clear lucite. Supplied sterile....
... x 100 mm. Storz offers the ... by Harvey A. Lincoff, M.D. ... sponge which is non-toxic and non-antigenic. ... to minimize scleral intrusion. These implants ...
... x 80 mm. Storz offers the ... by Harvey A. Lincoff, M.D. ... sponge which is non-toxic and non-antigenic. ... to minimize scleral intrusion. These implants ...
Medicine Products: